کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6182589 1254004 2016 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study
ترجمه فارسی عنوان
اثربخشی و ایمنی شیمیدرمانی نئوادجوانانت در درمان سرطان دهانه رحم محلی: یک مطالعه چندزیستی تصادفی
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
چکیده انگلیسی


- NACT reduces rate of patients requiring postoperative radiation by eliminating pathological risk factors, including LVSI and deep stromal invasion.
- IP as neoadjuvant chemotherapy has similar efficacy comparing to TP, but higher rates of neutropenia and diarrhea.
- LVSI was the only factor that indicates prognosis.

ObjectiveThis study sought to evaluate the toxicity and curative effect of irinotecan plus cisplatin neoadjuvant chemotherapy (NACT) for stage Ib2, IIa2, and IIb cervical cancer patients.MethodsA total of 219 patients were randomly assigned to two groups: 109 patients were treated with 1-2 cycles of chemotherapy (NACT group), and 110 patients in the control group were treated directly with surgery (DS group). Patients in the NACT group were randomly assigned to two groups: 50 patients were treated with irinotecan plus cisplatin followed by surgery (IP group), and 59 patients were treated with paclitaxel plus cisplatin followed by surgery (TP group). Patients with pathological recurrence risk factors received post-operative radiotherapy.ResultsSurvival analysis revealed no significant difference in disease-free survival (DFS) or overall survival (OS) between the NACT and DS groups. Analysis of clinicopathologic factors showed that the lymphovascular space invasion (LVSI) and deep stromal invasion rates were significantly lower in the NACT group. Grade 3/4 neutropenia and grade 3/4 diarrhea were both higher in the IP group than in the TP group. DFS and OS were similar in the IP and TP groups. Univariate analysis showed that LVSI was the only factor associated with DFS.ConclusionNACT did not improve overall survival but did reduce the number of patients who received post-operative radiotherapy. NACT consisting of irinotecan plus cisplatin for cervical cancer showed similar efficacy and higher toxicity compared with the use of paclitaxel plus cisplatin, although the toxicity was tolerable.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 141, Issue 2, May 2016, Pages 231-239
نویسندگان
, , , , , , , , ,